FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) Esomeprazole Magnesium Delayed-Release Recall

Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blist…

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · Rockford, IL

Risk level
Class II
Reported by FDA
May 18, 2022
Recall ID
D-0861-2022
Check your lot numberHow we source this data

Summary

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalled Esomeprazole Magnesium Delayed-Release starting Apr 1, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0861-2022 on May 18, 2022. Reason: Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.

Product description

Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Capsules each per carton), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC 42292-010-16

Lot numbers, UPCs & expiration codes

Lot #: 3110437, 3111409, 3110785, Exp. Date 7/31/2022; 3112173, Exp. Date 11/30/2022

Where it was sold

Nationwide within USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0861-2022
Classification
Class II
Status
Terminated
Recall initiated
Apr 1, 2022
FDA report date
May 18, 2022
Quantity
885 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Original FDA data

Every field from FDA enforcement report D-0861-2022, exactly as published.

Show all FDA fields
City
Rockford
State
IL
Status
Terminated
Country
United States
Event ID
89930
Address
1718 Northrock Ct
Code information
Lot #: 3110437, 3111409, 3110785, Exp. Date 7/31/2022; 3112173, Exp. Date 11/30/2022
Postal code
61103-1201
Report date
May 18, 2022
Product type
Drugs
Recall number
D-0861-2022
Classification
Class II
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Product quantity
885 cartons
Termination date
Jun 9, 2023
Reason for recall
Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Capsules each per carton), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC 42292-010-16
Distribution pattern
Nationwide within USA
Recall initiation date
Apr 1, 2022
Initial firm notification
Letter
Center classification date
May 11, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0861-2022, published May 18, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls